Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE923.757.4 (+0.81 %)
PREV CLOSE ( ) 916.35
OPEN PRICE ( ) 930.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34179
TODAY'S LOW / HIGH ( )918.50 931.30
52 WK LOW / HIGH ( )281.15 996.65
NSE924.256.95 (+0.76 %)
PREV CLOSE( ) 917.30
OPEN PRICE ( ) 921.40
BID PRICE (QTY) 924.25 (2777)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1408821
TODAY'S LOW / HIGH( ) 918.20 931.40
52 WK LOW / HIGH ( )288.85 996.85
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

24Dec Announcement under Regulation 30 (LOD
We enclose a copy of the Press Release that is being issued by the Compa..
24Dec Aurobindo Pharma, Tata Communications
Aurobindo Pharma has entered into an Exclusive License Agreement with CO..
24Dec Aurobindo Pharma enters into exclusive
Aurobindo Pharma has entered into an Exclusive License Agreement with CO..
24Dec Aurobindo Pharma gains on entering int
Aurobindo Pharma is currently trading at Rs. 897.95, up by 8.05 points o..
11Dec Announcement under Regulation 30 (LOD
We enclose a copy of the Press Release that is being issued by the Compa..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit8015.418727.4
Gross Profit 11292 23777
Operating Profit 12557.629437.6
Net Sales 45243.4132664.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  2750.50 (4.32%)
M.Cap ( in Cr)46540.86
Procter&Gamble Healt (BSE)
peergroup  6806.50 (1.38%)
M.Cap ( in Cr)11298.37
Ajanta Pharma (BSE)
peergroup  1793.90 (3.03%)
M.Cap ( in Cr)15522.93
Mercury Laboratories (BSE)
peergroup  646.00 (6.60%)
M.Cap ( in Cr)77.52
Divis Lab (BSE)
peergroup  3601.30 (1.03%)
M.Cap ( in Cr)95603.20

Shareholding Pattern

PROMOTERS 52.01%
FII 23.01%
NON-INSTITUTION 11.31%
MUTUAL FUNDS/UTI 11.02%
FI/BANKS/INSURANCE 0.17%
GOVERNMENT 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 916.35. Its current market capitalisation stands at Rs 54126.08 Cr. In the latest quarter, company has reported Gross Sales of Rs. 133097.4 Cr and Total Income of Rs.136698.5 Cr. The company's management includes K Nithyananda Reddy, Savita Mahajan, Avnit Bimal Singh, M Sitarama Murty, P V Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, N Govindarajan, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are ACC Ltd. It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)